Aurobindo Pharma surges on reporting over 9% rise in Q1 consolidated net profit
Follow us Now on Telegram ! Get daily 10 - 12 important updates on Business, Finance and Investment. Join our Telegram Channel
https://t.me/InvestmentGuruIndiacom
Download Telegram App before Joining the Channel
Aurobindo Pharma is currently trading at Rs. 885.45, up by 22.40 points or 2.60% from its previous closing of Rs. 863.05 on the BSE.
The scrip opened at Rs. 864.75 and has touched a high and low of Rs. 887.20 and Rs. 851.10 respectively. So far 58531 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 887.20 on 14-Aug-2023 and a 52 week low of Rs. 397.30 on 03-Feb-2023.
Last one week high and low of the scrip stood at Rs. 887.20 and Rs. 839.70 respectively. The current market cap of the company is Rs. 51199.32 crore.
The promoters holding in the company stood at 51.83%, while Institutions and Non-Institutions held 39.86% and 8.31% respectively.
Aurobindo Pharma has reported results for first quarter ended June 30, 2023 (Q1FY24). The company has reported over 2-fold jump in its net profit at Rs 335.95 crore for the quarter under review as compared to Rs 122.16 crore for the same quarter in the previous year. Total income of the company increased by 39.68% at Rs 2,485.70 crore for Q1FY24 as compared Rs 1,779.53 crore for the corresponding quarter previous year.
On consolidated basis, the company has reported 9.48% rise in its net profit at Rs 569.71 crore for the first quarter ended June 30, 2023 as compared to Rs 520.38 crore for the same quarter in the previous year. Total income of the company increased by 11% at Rs 6,966.85 crore for Q1FY24 as compared Rs 6,276.54 crore for the corresponding quarter previous year.
